Relevant bibliographies by topics / Soluble interleukin-2 receptor

Academic literature on the topic 'Soluble interleukin-2 receptor'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Soluble interleukin-2 receptor.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Soluble interleukin-2 receptor"

1

Murakami, Saburo. "Soluble interleukin-2 receptor in cancer." Frontiers in Bioscience 9, no. 1-3 (2004): 3085. http://dx.doi.org/10.2741/1461.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Huang, Andy, and Kirsten S. Hindle. "Serum soluble interleukin-2-receptor concentrations." Lancet 358, no. 9278 (July 2001): 330. http://dx.doi.org/10.1016/s0140-6736(01)05505-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lai, Kar Neng, Joseph C. K. Leung, Chun Chung Chow, and Clive S. Cockram. "T lymphocyte activation in euthyroid Graves' ophthalmopathy: soluble interleukin 2 receptor release, cellular interleukin 2 receptor expression and interleukin 2 production." Acta Endocrinologica 120, no. 5 (May 1989): 602–9. http://dx.doi.org/10.1530/acta.0.1200602.

Full text
Abstract:
Abstract. The present study was undertaken to examine the cellular control arm of the immune response with regard to T lymphocyte proliferation in euthyroid Graves' ophthalmopathy. Twenty patients with euthyroid Graves' ophthalmopathy (7 on antithyroid drugs and 13 on no treatment) and 18 healthy controls were studied in an infection-free period. Mitogen-stimulated cellular interleukin 2 (IL2) receptor expression, soluble interleukin 2 receptor release, and interleukin 2 production, were studied in peripheral blood mononuclear cells cultured for 24 h. The cellular IL2 receptor expression and soluble IL2 receptor release did not differ between the patients and healthy controls. In contrast, IL2 production in response to pokeweed mitogen stimulation was increased in lymphocytes from patients with Graves' ophthalmopathy. The IL2 release did not correlate with the quantities of cellular and soluble IL2 receptor. The mitogen-stimulated cellular IL2 receptor expression, IL2 receptor release, and IL2 production did not differ between patients with or without carbimazole therapy. Despite a suggested role of autoreactive T cells in mediating the development and propagation of autoimmune thyroid disease, this study fails to demonstrate a defective T lymphocyte activation state in patients with Graves' ophthalmopathy during an euthyroid state.
APA, Harvard, Vancouver, ISO, and other styles
4

Kaito, Ken, Hiroko Otsubo, Yoji Ogasawara, Hiroko Kimura, Etsuko Kurihara, Masaru Koike, Masayoshi Aiso, and Masayuki Kobayashi. "Serum Soluble Interleukin-2 Receptor in Eosinophilia." Acta Haematologica 109, no. 1 (December 23, 2002): 23–28. http://dx.doi.org/10.1159/000067274.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Buccheri, Gianfranco, Pietro Marino, Armando Preatoni, Domenico Ferrigno, and Gianni A. Moroni. "Soluble Interleukin 2 Receptor in Lung Cancer." Chest 99, no. 6 (June 1991): 1433–37. http://dx.doi.org/10.1378/chest.99.6.1433.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Valsecchi, R., M. Bontempelli, A. Di Landro, G. Imberti, and T. Cainelli. "Soluble interleukin-2 receptor in lichen planus." British Journal of Dermatology 125, no. 4 (October 1991): 403–4. http://dx.doi.org/10.1111/j.1365-2133.1991.tb14186.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wyman, Michael L., and William D. Engle. "Usefulness of soluble interleukin-2 receptor specificity." Journal of Pediatrics 128, no. 3 (March 1996): 445. http://dx.doi.org/10.1016/s0022-3476(96)70317-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hisamatsu, Ken-ichi, Tetsuya Ganbo, Tsutomu Nakazawa, Shin-ichi Shimomura, Shigetoshi Horiguchi, Mayumi Nakajima, Yoshihiko Murakami, and Hazime Inoue. "Soluble Interleukin-2 Receptor in Nasal Allergy." Practica oto-rhino-laryngologica. Suppl. 1995, Supplement79 (1995): 153–57. http://dx.doi.org/10.5631/jibirinsuppl1986.1995.supplement79_153.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shu, Kuo‐Hsiung, Yuan‐San Lu, Chi‐Hung Cheng, and Jong‐Da Lian. "Soluble Interleukin 2 Receptor in Dialyzed Patients." Artificial Organs 22, no. 2 (February 1998): 142–44. http://dx.doi.org/10.1046/j.1525-1594.1998.05062.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Colver, G. B., J. A. Symons, and G. W. Duff. "Soluble interleukin 2 receptor in atopic eczema." BMJ 298, no. 6685 (May 27, 1989): 1426–28. http://dx.doi.org/10.1136/bmj.298.6685.1426.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Soluble interleukin-2 receptor"

1

Barton, Desmond Patrick Joseph. "Soluble interleukin-2 receptor #alpha# levels and interleukin-2 receptor #alpha# expression in advanced epithelial ovarian cancer : immunologic implications." Thesis, Queen's University Belfast, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.261765.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kazim, Khalid Abdul Qader. "The usefulness of soluble interleukin-2 receptor and other protein markers in renal allograft rejection." Thesis, University of Sheffield, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312800.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Miller, Alice Lorraine 1953. "Serum levels of two immunological markers, the soluble low affinity receptor for IgE (sFCepsilonRII, sCD23) and soluble interleukin 2 receptor (sIL-2R), and their correlation with age, gender and the onset of childhood atopy." Thesis, The University of Arizona, 1993. http://hdl.handle.net/10150/278355.

Full text
Abstract:
Identifying predictive indicators of atopy could allow for the early intervention and/or prevention of atopic associated diseases within individuals identified to be at high risk. Two immunological factors advanced as candidates for such a role are sCD23 and sCD25. Soluble CD23 and CD25 expression were therefore examined in the cord blood of over 300 healthy newborns enrolled in the Tucson Children's Respiratory study. Additionally these factors were measured in sera drawn from these patients between the ages of 4-9. Determinations were made using commercially available sCD23 and sCD25 ELISA assays. Results indicate these markers are measurable in cord samples, they are not influenced by gender, and soluble CD23 and CD25 levels decrease with age. Increasing levels of sCD23 and sCD25 did not correlate with increasing expression of IgE. Experimental data derived in this study indicate these factors will not serve as independent, predictive indicators of future asthma, hayfever or eczema.
APA, Harvard, Vancouver, ISO, and other styles
4

CHEVALIER, SYLVIE. "Etude de la tolerance induite par des transfusions sanguines dans un modele de rat : etude de la forme soluble du recepteur a l'il2 dans un modele de rat, etude du deuxieme recepteur t : tcr gamma/delta chez l'homme." Nantes, 1988. http://www.theses.fr/1988NANT2011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chérel, Michel. "Construction d'un recepteur soluble de haute affinite pour l'interleukine 2 : clonage de l'adn complementaire et du gene du recepteur a l'interleukine 11 humaine." Nantes, 1995. http://www.theses.fr/1995NANT10VS.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Flory, Eric. "Contribution a l'etude des recepteurs soluble et membranaire de l'interleukine 2 au cours des hemopathies lymphoides." Université Louis Pasteur (Strasbourg) (1971-2008), 1991. http://www.theses.fr/1991STR1M224.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mendel, Isabelle. "Contribution a l'etude des recepteurs solubles de l'interleukine 2 au cours de l'infection par le virus de l'immunodeficience humaine." Université Louis Pasteur (Strasbourg) (1971-2008), 1991. http://www.theses.fr/1991STR1M034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

François-Bendahou, Christine. "Etude de combinaisons synergiques d'anticorps monoclonaux anti-chaine a et b du recepteur a l'il2 et d'un anticorps bispecifique anti-a/anti-b : production d'une chaine b soluble et developpement d'anticorps monoclonaux anti-chaine b." Nantes, 1994. http://www.theses.fr/1994NANT02VS.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

McGregor, Neil Roland. "An investigation of the association between toxin producing staphylococcus, biochemical changes and jaw muscle pain." University of Sydney. Prosthetic Dentistry, 2000. http://hdl.handle.net/2123/369.

Full text
Abstract:
Objectives: To assess the expression of the symptoms of jaw muscle pain and its association with alterations in biochemistry, other symptoms and the carriage of staphylococci. Methods: Three different study populations were assessed. The first was selected and examined by the author and consisted of 43 pain and 41 age and sex matched controls. The second was a study of CFS patients who were blinded to the author and the author subsequently examined the associations between jaw muscle symptom reporting and the standardised biochemistry measures. The third study was also blinded to the author but included an investigation of staphylococci and certain cytokine and biochemistry measures. Results: The three studies clearly establish an association between the carriage of toxicogenic coagulase negative staphylococci and the expression of jaw muscle pain in both males and females. These associations were homogeneous and were found whether the patients were selected on the basis of having jaw muscle pain or selected from within a population of patients selected on the basis of having Chronic Fatigue Syndrome. The studies associated the changes with variations in biochemistry and these were in turn associated with symptom expression within the jaw muscle pain patients. These biochemical alterations included the dysregulation of immune cell counts, cytokines, electrolyte and protein metabolism. These symptoms and biochemical changes were associated with pain severity and illness duration and staphylococcal toxin production. From the data a model was developed which shows the mechanisms involved in the development of chronic pain in the jaw muscles. Conclusions: The carriage of toxicogenic coagulase-negative staphylococci were found to be associated with the expression of jaw muscle pain and the alterations in biochemistry associated with these symptoms.
APA, Harvard, Vancouver, ISO, and other styles
10

McGregor, Neil Roland. "An investigation of the association between toxin producing staphylococcus, biochemical changes and jaw muscle pain." Thesis, The University of Sydney, 1999. http://hdl.handle.net/2123/369.

Full text
Abstract:
Objectives: To assess the expression of the symptoms of jaw muscle pain and its association with alterations in biochemistry, other symptoms and the carriage of staphylococci. Methods: Three different study populations were assessed. The first was selected and examined by the author and consisted of 43 pain and 41 age and sex matched controls. The second was a study of CFS patients who were blinded to the author and the author subsequently examined the associations between jaw muscle symptom reporting and the standardised biochemistry measures. The third study was also blinded to the author but included an investigation of staphylococci and certain cytokine and biochemistry measures. Results: The three studies clearly establish an association between the carriage of toxicogenic coagulase negative staphylococci and the expression of jaw muscle pain in both males and females. These associations were homogeneous and were found whether the patients were selected on the basis of having jaw muscle pain or selected from within a population of patients selected on the basis of having Chronic Fatigue Syndrome. The studies associated the changes with variations in biochemistry and these were in turn associated with symptom expression within the jaw muscle pain patients. These biochemical alterations included the dysregulation of immune cell counts, cytokines, electrolyte and protein metabolism. These symptoms and biochemical changes were associated with pain severity and illness duration and staphylococcal toxin production. From the data a model was developed which shows the mechanisms involved in the development of chronic pain in the jaw muscles. Conclusions: The carriage of toxicogenic coagulase-negative staphylococci were found to be associated with the expression of jaw muscle pain and the alterations in biochemistry associated with these symptoms.
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Soluble interleukin-2 receptor"

1

Crabtree, J. E., R. V. Heatley, L. D. Juby, P. D. Howdle, and M. S. Losowsky. "Soluble interleukin-2 receptor (sIL-2R) in coeliac disease." In Advances in Mucosal Immunology, 738–41. Dordrecht: Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-009-1848-1_228.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kaden, J., B. Schütze, and G. May. "A critical analysis of soluble interleukin-2 receptor levels in kidney allograft recipients." In Transplant International, 63–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-00818-8_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Siegert, W., O. Josimovic-Alasevic, R. Schwerdtfeger, C. Schmidt, A. Neubauer, G. Henze, D. Huhn, and T. Diamantstein. "Determination of Soluble Interleukin-2 Receptors After Bone Marrow Transplantation." In Acute Leukemias II, 76–77. Berlin, Heidelberg: Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-74643-7_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stankovic, Sanja, Mihailo Stjepanovic, and Milika Asanin. "Biomarkers in Idiopathic Pulmonary Fibrosis." In Idiopathic Pulmonary Fibrosis [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.100042.

Full text
Abstract:
Numerous published papers are investigating the utility of biomarkers in Idiopathic Pulmonary Fibrosis (IPF) diagnosis, treatment, and outcome prediction. This chapter will summarize our current knowledge about biomarkers associated with alveolar epithelial cell damage and dysfunction (Krebs von den Lungen, surfactant proteins, the mucin MUC5B, CA 15-3, CA 125, CA 19-9, defensins, Clara cell protein (CC16), telomere shortening), biomarkers associated with fibrogenesis, fibroproliferation and extracellular matrix (ECM) remodeling (MMPs and their inhibitors, osteopontin, periostin, insulin-like growth factors, fibulin-1, heat shock protein 47, lysyl oxidase-like 2, circulating fibroblasts, extracellular matrix neoepitopes) and biomarkers related to immune dysfunction and inflammation (C-C chemokine ligand-18, C-C chemokine 2, YKL-40, C-X-C motif chemokine 13, S100A4, S100A8/9, S100A12, autoantibodies to heat shock protein 72, toll-like receptor 3, soluble receptor for advanced glycosylated end products, endothelial damage (vascular endothelial growth factor, interleukin 8, endothelin 1). The future directions in incorporating IPF biomarkers into clinical practice will be reviewed.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Soluble interleukin-2 receptor"

1

Akiyama, M., T. Sasaki, Y. Kaneko, H. Yasuoka, K. Suzuki, K. Yamaoka, and T. Takeuchi. "FRI0590 Soluble interleukin-2 receptor levels reflect disease activity in IGG4-related disease and primary sjÖgren's syndrome." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gupta, S., S. M. Farooqui, M. Parmar, R. P. Padappayil, and S. Daouk. "Role of Serum Soluble Interleukin-2 Receptor Level in the Diagnosis of Sarcoidosis: A Systematic Review and Meta-Analysis." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4881.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sakamoto, N., S. Hara, H. Ishimoto, S. Nakashima, H. Yura, T. Miyamura, D. Okuno, et al. "Serum Soluble Interleukin-2 Receptor Is a Candidate Marker Differentiating Pneumocystis Jirovecii Pneumonia and Methotrexate-Induced Pneumonia in Patients with Rheumatoid Arthritis Under Methotrexate Therapy." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Soluble interleukin-2 receptor' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography